| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.94B | 18.94B | 18.49B | 17.46B | 16.25B | 14.63B |
| Gross Profit | 9.97B | 9.97B | 9.82B | 9.07B | 8.47B | 7.72B |
| EBITDA | 4.22B | 4.22B | 4.35B | 3.98B | 3.72B | 3.36B |
| Net Income | 2.50B | 2.50B | 2.66B | 2.53B | 2.43B | 2.17B |
Balance Sheet | ||||||
| Total Assets | 19.36B | 19.36B | 17.18B | 15.99B | 15.28B | 14.52B |
| Cash, Cash Equivalents and Short-Term Investments | 271.80M | 271.80M | 298.17M | 277.05M | 264.38M | 1.17B |
| Total Debt | 12.18B | 12.18B | 12.37B | 10.93B | 9.30B | 8.23B |
| Total Liabilities | 22.77B | 22.77B | 21.93B | 20.34B | 18.81B | 16.31B |
| Stockholders Equity | -3.41B | -3.41B | -4.75B | -4.35B | -3.54B | -1.80B |
Cash Flow | ||||||
| Free Cash Flow | 1.79B | 1.79B | 1.93B | 2.14B | 2.54B | 2.90B |
| Operating Cash Flow | 3.12B | 3.12B | 3.00B | 2.94B | 3.21B | 3.52B |
| Investing Cash Flow | -1.40B | -1.40B | -1.29B | -876.18M | -648.10M | -601.78M |
| Financing Cash Flow | -1.75B | -1.75B | -1.68B | -2.06B | -3.47B | -3.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $3.87B | 15.76 | 18.19% | ― | 7.94% | 34.84% | |
65 Neutral | $7.54B | 10.93 | 10.87% | 4.07% | -3.71% | -0.27% | |
65 Neutral | $802.75M | 11.88 | 10.49% | 3.40% | 23.96% | 11.01% | |
64 Neutral | $63.58B | 26.38 | ― | ― | 2.43% | -3.34% | |
64 Neutral | $9.26B | 69.38 | 2.24% | 1.29% | 0.08% | -83.69% | |
63 Neutral | $83.47B | 34.26 | ― | ― | 6.19% | 6.98% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |
On October 8, 2025, AutoZone‘s Board of Directors approved the transition of William C. Rhodes, III from Executive Chairman to Chairman, effective January 2026, with compensation adjusted to standard non-employee director policies and an annual $250,000 in restricted stock units. Additionally, the Board authorized an extra $1.5 billion for its share repurchase program, bringing the total authorization since 1998 to $40.7 billion, reflecting the company’s strong capital allocation strategy and commitment to shareholder value.